BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 30599775)

  • 21. Targeting the Oncogenic Transcriptional Regulator MYB in Adenoid Cystic Carcinoma by Inhibition of IGF1R/AKT Signaling.
    Andersson MK; Afshari MK; Andrén Y; Wick MJ; Stenman G
    J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28954282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of Slug is regulated by c-Myb and is required for invasion and bone marrow homing of cancer cells of different origin.
    Tanno B; Sesti F; Cesi V; Bossi G; Ferrari-Amorotti G; Bussolari R; Tirindelli D; Calabretta B; Raschellà G
    J Biol Chem; 2010 Sep; 285(38):29434-45. PubMed ID: 20622260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Arf-inducing transcription factor Dmp1 encodes a transcriptional activator of amphiregulin, thrombospondin-1, JunB and Egr1.
    Mallakin A; Sugiyama T; Kai F; Taneja P; Kendig RD; Frazier DP; Maglic D; Matise LA; Willingham MC; Inoue K
    Int J Cancer; 2010 Mar; 126(6):1403-16. PubMed ID: 19816943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. c-Myb and members of the c-Ets family of transcription factors act as molecular switches to mediate opposite steroid regulation of the human glucocorticoid receptor 1A promoter.
    Geng CD; Vedeckis WV
    J Biol Chem; 2005 Dec; 280(52):43264-71. PubMed ID: 16263717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of Myb protein and downstream target genes in salivary adenoid cystic carcinoma.
    Bell D; Roberts D; Karpowicz M; Hanna EY; Weber RS; El-Naggar AK
    Cancer Biol Ther; 2011 Oct; 12(7):569-73. PubMed ID: 21785271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphoid enhancer-binding factor-1 binds and activates the recombination-activating gene-2 promoter together with c-Myb and Pax-5 in immature B cells.
    Jin ZX; Kishi H; Wei XC; Matsuda T; Saito S; Muraguchi A
    J Immunol; 2002 Oct; 169(7):3783-92. PubMed ID: 12244173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
    Pastorino F; Brignole C; Marimpietri D; Di Paolo D; Zancolli M; Pagnan G; Ponzoni M
    Ann N Y Acad Sci; 2004 Dec; 1028():90-103. PubMed ID: 15650235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathologic implications of Myb and Beta-catenin expression in adenoid cystic carcinoma.
    Park S; Vora M; van Zante A; Humtsoe J; Kim HS; Yom S; Agarwal S; Ha P
    J Otolaryngol Head Neck Surg; 2020 Jul; 49(1):48. PubMed ID: 32650834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A DNA uptake-stimulating protein increases the antiproliferative effect of c-myb antisense oligonucleotide on leukemic cells.
    Tóth G; Schlammadinger J; Aradi J; Antal-Szalmás P; Sipka S; Balázs M; Kovács P; Fehér Z; Falus A
    Cell Biol Int; 2004; 28(11):817-23. PubMed ID: 15563404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Convergent organization of aberrant MYB complex controls oncogenic gene expression in acute myeloid leukemia.
    Takao S; Forbes L; Uni M; Cheng S; Pineda JMB; Tarumoto Y; Cifani P; Minuesa G; Chen C; Kharas MG; Bradley RK; Vakoc CR; Koche RP; Kentsis A
    Elife; 2021 Feb; 10():. PubMed ID: 33527899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune cell-mediated antitumor activities of GD2-targeted liposomal c-myb antisense oligonucleotides containing CpG motifs.
    Brignole C; Pastorino F; Marimpietri D; Pagnan G; Pistorio A; Allen TM; Pistoia V; Ponzoni M
    J Natl Cancer Inst; 2004 Aug; 96(15):1171-80. PubMed ID: 15292389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific protein redirection as a transcriptional therapy approach for t(8;21) leukemia.
    Steffen B; Serve H; Berdel WE; Agrawal S; Linggi B; Büchner T; Hiebert SW; Müller-Tidow C
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8448-53. PubMed ID: 12819347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deep sequencing and in silico analyses identify MYB-regulated gene networks and signaling pathways in pancreatic cancer.
    Azim S; Zubair H; Srivastava SK; Bhardwaj A; Zubair A; Ahmad A; Singh S; Khushman M; Singh AP
    Sci Rep; 2016 Jun; 6():28446. PubMed ID: 27354262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children.
    Clappier E; Cuccuini W; Kalota A; Crinquette A; Cayuela JM; Dik WA; Langerak AW; Montpellier B; Nadel B; Walrafen P; Delattre O; Aurias A; Leblanc T; Dombret H; Gewirtz AM; Baruchel A; Sigaux F; Soulier J
    Blood; 2007 Aug; 110(4):1251-61. PubMed ID: 17452517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Naphthol AS-E Phosphate Inhibits the Activity of the Transcription Factor Myb by Blocking the Interaction with the KIX Domain of the Coactivator p300.
    Uttarkar S; Dukare S; Bopp B; Goblirsch M; Jose J; Klempnauer KH
    Mol Cancer Ther; 2015 Jun; 14(6):1276-85. PubMed ID: 25740244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of murine hematopoietic stem cell quiescence by Dmtf1.
    Kobayashi M; Srour EF
    Blood; 2011 Dec; 118(25):6562-71. PubMed ID: 22039255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. c-Myb associates with PML in nuclear bodies in hematopoietic cells.
    Dahle Ø; Bakke O; Gabrielsen OS
    Exp Cell Res; 2004 Jul; 297(1):118-26. PubMed ID: 15194430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of c-Myb with p300 is required for the induction of acute myeloid leukemia (AML) by human AML oncogenes.
    Pattabiraman DR; McGirr C; Shakhbazov K; Barbier V; Krishnan K; Mukhopadhyay P; Hawthorne P; Trezise A; Ding J; Grimmond SM; Papathanasiou P; Alexander WS; Perkins AC; Levesque JP; Winkler IG; Gonda TJ
    Blood; 2014 Apr; 123(17):2682-90. PubMed ID: 24596419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monensin, a novel potent MYB inhibitor, suppresses proliferation of acute myeloid leukemia and adenoid cystic carcinoma cells.
    Yusenko MV; Trentmann A; Andersson MK; Ghani LA; Jakobs A; Arteaga Paz MF; Mikesch JH; Peter von Kries J; Stenman G; Klempnauer KH
    Cancer Lett; 2020 Jun; 479():61-70. PubMed ID: 32014461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The carbonic anhydrase I locus contains a c-Myb target promoter and modulates differentiation of murine erythroleukemia cells.
    Chen J; Kremer CS; Bender TP
    Oncogene; 2006 May; 25(19):2758-72. PubMed ID: 16407849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.